Shrimp EMS Treatment Composition Using Turkey Tail Mushroom Extract and Chitosan
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing and treating Early Mortality Syndrome (EMS) in shrimp, such as using antibiotics and disinfectants, are ineffective and harmful to the environment and animal health, and there is a need for a detailed process to create a composition using turkey tail mushroom extract and chitosan to replace antibiotics.
Innovation Solution
A process involving the mixing of turkey tail mushroom extract and chitosan with other ingredients like carboxymethyl cellulose, alginate, and essential oils, followed by specific pH adjustments and incubation conditions to create a composition that can be used to prevent and treat EMS in shrimp.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics and disinfectants are used to prevent and treat EMS in shrimp, then disease prevention effectiveness is improved, but environmental harm and harm to animal health worsen
Solution Approach 1:
The patent changes the chemical composition parameters by replacing synthetic antibiotics with natural compounds (turkey tail mushroom extract and chitosan) that have different biochemical properties, achieving disease prevention without the harmful side effects of conventional antibiotics
Solution Approach 2:
The patent creates a composite composition combining turkey tail mushroom extract (containing polysaccharides and beta-glucans) with chitosan (a polysaccharide from crustacean shells), forming a synergistic natural alternative that enhances immune stimulation and antibacterial activity while avoiding environmental contamination
2Object-affected harmful factors
If natural compounds from plants are used to replace antibiotics, then environmental safety and animal health improve, but manufacturing complexity increases
Solution Approach 1:
The patent divides the manufacturing process into distinct sequential steps: extracting active compounds from turkey tail mushrooms, separately preparing chitosan solution, mixing these with supporting ingredients (carboxymethyl cellulose, alginate, essential oils), and performing pH adjustment and incubation. This segmentation makes the complex natural compound manufacturing manageable and reproducible
Solution Approach 2:
The patent uses chitosan as an intermediary substance that bridges the gap between natural plant extracts and the final functional composition. Chitosan serves as both a carrier and an active ingredient, facilitating the delivery of turkey tail mushroom compounds while contributing its own antibacterial and immune-modulating properties
3Reliability
If complex composition with multiple ingredients is prepared, then treatment effectiveness improves, but manufacturing time and process complexity increase
Solution Approach 1:
The patent performs preliminary extraction of active compounds from turkey tail mushrooms before final composition assembly. This advance preparation of the mushroom extract (obtaining a concentrated solution ready for mixing) reduces the time required during final manufacturing, as the active ingredients are pre-isolated and ready for immediate formulation with other components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively prevents and treats EMS in shrimp, enhancing their immune system and survival rate while being environmentally friendly and safe for consumption.
Implementation Method 1
adjusting the pH to 6.5-7.5
Implementation Method 2
leaving it for one day at a temperature of 30° C.-35° C.
Data Source
AI summary
A composition for prevention and treatment of Early Mortality Syndrome (EMS) shrimp to replace antibiotics obtain from process creating a basic mixture by mixing a complex composition with mixing ingredients, then stirring the basic mixture for 1 hour, and adjusting the pH to 6.5-7.5 and leaving it for one day at a temperature of 30° C.-35° C.; wherein the complex composition including 10%-15% by weight of a turkey tail mushroom extract and 10%-15% by weight of a chitosan; in which mixing ingredients consisting of a carboxymethyl cellulose solution 0.375%, a alginate solution 0.375%, a potassium citrate solution, a AgNO3 solution 0.37%, a Cu(NO3)2 solution 0.723%, a Zn(NO3)2 solution 3.085%, Co(NO3)2 solution 0.746%, a Fe(NO3)3 solution 2.5%, a glycerin ingredient, a vitamin E, a tartrazine ingredient 1%, a K2HPO4 solution 15%, a mixture extracts/essential oils, and an other ingredient.
